Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 5 days agoAlliance revenues from Lynparza and Lenvima are also boosting Merck’s oncology sales. Animal health ...
MRK- A Big Pharma Name Growing Via Acquisitions, Product Launches
MoneyShow via Yahoo Finance· 1 week agoMerck & Co. (MRK) is a leading global drugmaker, producing a wide range of prescription drugs and vaccines in many therapeutic areas ...
Merck Expands Access to High-Quality Maternal Care for More
3BL CSRwire· 2 weeks agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global ...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 1 week agoWith continued label expansion into new indications, particularly earlier-stage launches, Keytruda...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 weeks agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoGlobalData, the parent company...s strategic asset”, sector association Sindusfarma is highlights Brazil’s role in global efforts to research and produce...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 2 weeks agoIn partnership with Moderna MRNA, Merck is developing a personalized mRNA therapeutic cancer vaccine...
HPV vaccine provides real benefits for men, analysis shows By Reuters
Investing.com· 2 days agoHPV vaccine provides real benefits for men, analysis shows
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 2 weeks agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 1 day agoBut that was largely due to flagging sales of its COVID-19 vaccine and Paxlovid treatment for...